Patent ID: 8591964

Claim:
A method for treating inflammation linked to a disorder in an animal, which comprises the steps of a) obtaining one or more plants selected from the group consisting of V. alaskensis, V. axillare, V. caespitosum, V. caespitosum var. paludicola, V. membranaceum, V. parvifolium, V. ovalifolium, V. oxycoccus, V. shikokianum, V. uliginosum subsp. alpinum, V. uliginosum var. salicinum, V. uliginosum subsp. microphyllum, V. vitis - idaea subsp. minus , and V. vitis - idaea subsp. vitis - idaea , wherein said one or more plants have grown under the following conditions: i. Subject to one or more uninterrupted photoperiod(s) of at least about 18 hours to 24 hours per day for about 60 days during flowering and fruit setting; ii. Subject to one or more uninterrupted photoperiod(s) of at least about 15 hours per day for about 30 days during fruit ripening and maturity; and iii. Subject to growth for at least 7 days past peak fruit ripeness; (b) drying parts comprising one or more berries, and optionally one or more members of the group consisting of leaves, roots, and root bark, of said one or more plants; (c) milling said dried parts of said one or more plants into a fine powder; (d) formulating a composition comprising the fine powder in dosage form; and (e) administering to said animal an effective amount of the composition; wherein said disorder is diabetes mellitus; wherein said composition comprises, at least in part, a metabolite produced by one or more stress-related phenylpropanoid pathway(s); and wherein said administering is accomplished orally.